FI
Fady Ibraham Malik sold $181K of CYTK stock
Fady Ibraham Malik, EVP Research & Development of Cytokinetics Inc (CYTK), sold 3,500 shares of CYTK stock worth $181K, per an SEC Form 4 filed Nov 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 17, 2026, 1 day before it was made public.
CYTK has moved -0.4% since the trade date, from $51.65 to $51.46 (Nov 19, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 1 day
- Price since
- -0.4%
- Role
- EVP Research & Development
- Source
- SEC Form 4